Natera Inc (NTRA)

Natera Inc (NTRA) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $58.2B; returns 1 day +0.6%, 1 week +2.7%, 1 year +107.2%.

Natera, Inc. is a global leader in cell-free DNA (cfDNA) testing and precision medicine, focusing on oncology, women's health, and organ health. The company develops and commercializes genetic testing technologies for clinical applications.

Groups NTRA belongs to

NTRA financial model: income statement, cash flow and balance sheet